Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a protective group strategy in peptide and heterocyclic chemistry, enabling selective reactions at other functional sites. Its cyclic hydroxylamine structure allows for incorporation into bioactive molecules where controlled release or metabolic stability is required. Commonly applied in medicinal chemistry for optimizing drug candidates targeting central nervous system disorders and inflammatory diseases.